Evidence map›Paper›PMID 41591189›Full record

ArticleToxins2026

Presynaptic Terminal Proteins and Nicotinic Receptors Are Depleted from Mouse Parasympathetic Ganglionic Junctions Paralysed with Botulinum Neurotoxin Type A.

Ahmed Al-Sabi, Gary W Lawrence

Abstract read
In one paragraph

Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmed Al-SabiSchool of Biotechnology, Dublin City University, D09 K20V Dublin, Ireland.ORCID 0000-0002-1957-7569
Gary W LawrenceSchool of Biotechnology, Dublin City University, D09 K20V Dublin, Ireland.ORCID 0000-0002-5206-7763

Funding

Science Foundation Ireland 09/IN.1/B2634
6 · The paper itself

Abstract

Plasticity is fundamental to the development, strengthening, and maintenance of healthy synaptic connections and recovery from injury in both the central and peripheral nervous systems. Yet, the processes involved are poorly understood. Herein, using a combination of patch-clamp electrophysiology and immuno-fluorescence confocal microscopy in adult mice, it is shown that blockade of synaptic transmission at submandibular ganglion junctions exposed to botulinum neurotoxin type A was accompanied by a rapid and striking decline in the abundance of synaptic vesicle markers-SV2, vesicle-associated membrane protein 2, and vesicular acetylcholine transporter-plus SNAP-25 (cleaved and intact) and postsynaptic α7 nicotinic acetylcholine receptors. Such alterations by the neurotoxin of parasympathetic synapses contrast starkly with the stability of postsynaptic proteins at nearby skeletal neuromuscular junctions. Both neurotransmission and the expression of SV2 and α7 nicotinic acetylcholine receptors remained depressed for 4 weeks, with full recovery of synaptic function delayed for more than 8 weeks. These novel findings may explain the relatively slow recovery of autonomic function after botulism or following therapeutic injections to alleviate hypersecretory disorders.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorBotulinum Toxins, Type AGanglia, ParasympatheticPresynaptic TerminalsReceptors, NicotinicAnimalsMaleMiceMice, Inbred C57BLNeuromuscular JunctionSynaptic TransmissionSynaptosomal-Associated Protein 25alpha7 Nicotinic Acetylcholine ReceptorBotulinum Toxins, Type AReceptors, NicotinicSnap25 protein, mouseSynaptosomal-Associated Protein 25acetylcholinebotulinum neurotoxinganglionic neurotransmissionhypersalivationsalivary ductSNAREssubmandibular ganglionsynaptic plasticity

Identifiers

PMID41591189
PMCPMC12846174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.